Rare diseases
Investigational molecules
Locations
Back to Poland302 clinical trials in Olsztyn, Poland across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function
PolandStudy on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis
PolandStudy of Atezolizumab and Tiragolumab Compared to Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemoradiation
PolandStudy on Trastuzumab Deruxtecan for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
PolandStudy on Batoclimab for Patients with Thyroid Eye Disease
PolandStudy on the Effectiveness of Bimatoprost SR for Patients with Open-Angle Glaucoma or Ocular Hypertension
PolandStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
PolandStudy of Zanubrutinib and Tacrolimus for Patients with Primary Membranous Nephropathy
PolandStudy on Brentuximab Vedotin, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma
PolandStudy on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)
PolandStudy of Pembrolizumab and Olaparib with Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer
PolandStudy on Long-term Safety and Effectiveness of Bimatoprost SR for Patients with Open-angle Glaucoma or Ocular Hypertension
PolandThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on acute myeloid leukemia treatments and innovative therapies for various types of lung cancer. Studies include evaluation of new drug combinations and treatment approaches for colorectal cancer and lymphoma.
Research emphasizes personalized medicine approaches and improving patient outcomes in advanced stages of disease.
Innovative research into plaque psoriasis and psoriatic arthritis treatments, including new biological therapies and novel drug combinations. Studies also examine treatments for rare conditions like pyoderma gangrenosum.
Focus on developing more effective treatments for moderate to severe skin conditions.
Studies examining new approaches to heart failure prevention and treatment, including investigations of novel drug combinations. Research focuses on reducing cardiovascular events and improving outcomes in high-risk patients.
Emphasis on preventive measures and innovative treatment strategies for cardiac conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
